Prestige Consumer Healthcare Inc.
PBH· NYSE
Filed May 7, 2021 · 10-K · 37 days after period end · 0001295947-21-000021
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $237.76M | $251.24M | $241.03M | $255.97M |
| Net Income | $35.51M | $37.05M | -$139.27M | -$39.69M |
| EPS Diluted | — | $0.73 | -$2.68 | -$0.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 7, 2021 · 37 d after period end